Buried knowledge could cost pharma billions. Here’s how to fix it
A global pharmaceutical company already has the competitive report it needs. The problem is that...
Read More
Author: John Pinching
Study highlights advance in influenza protection for older adults
Phase 3 data supports combined vaccine technologies
Read More
NICE backs daratumumab quadruplet for transplant‑eligible myeloma
Guidance supports MRD‑guided treatment approach
Read More
Teitur reports positive early data for Parkinson’s peptide TT‑P34
Phase 1 trial shows strong safety and CNS exposure
Read More
Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer
New data shows nearly three‑year median overall survival
Read More
